Article
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
BMC infectious diseases - 20 Jul 2010
Gonçales Fernando L, Moma Camila A, Vigani Aline G, Angerami Adriana F C F, Gonçales Eduardo S L, Tozzo Raquel, Pavan Maria H P, Gonçales Neiva S L
Abstract excerpt
BACKGROUND: More than 50% of hepatitis C viruses (HCV)-infected patients do not respond to the classical Interferon (IFN)/Ribavirin (RBV) combination therapy. The aim of this study was to evaluate the efficacy of retreatment with Peg-Interferon alpha-2b (PEG-IFN alpha-2b) plus RBV, in patients with HCV, genotypes 1 or 3, who were non-responders to the previous standard treatment with IFN/RBV. METHODS: In the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.